{
    "root": "2f9efac1-0a4b-d80e-e063-6294a90adaa9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "AMLODIPINE BESYLATE",
    "value": "20250305",
    "ingredients": [
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ],
    "indications": {
        "text": "amlodipine besylate tablets calcium channel blocker may used alone combination antihypertensive antianginal agents treatment : hypertension ( 1.1 ) amlodipine besylate tablets indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . coronary artery disease ( 1.2 ) chronic stable angina vasospastic angina ( prinzmetal \u2019 variant angina ) angiographically documented coronary artery disease patients without heart failure ejection fraction < 40 % .",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "coronary artery disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "artery disease (DOID:0050828)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050828"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "variant angina (DOID:0111151)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0111151"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "chronic stable angina",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_458775"
            }
        ]
    },
    "contraindications": {
        "text": "adult recommended starting dose : 5 mg daily maximum dose 10 mg daily . ( 2.1 ) small , fragile , elderly patients , patients hepatic insufficiency may started 2.5 mg daily . ( 2.1 ) pediatric starting dose : 2.5 mg 5 mg daily . ( 2.2 ) important limitation : doses excess 5 mg daily studied pediatric patients . ( 2.2 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "10 mg tablets amlodipine besylate tablets , usp equivalent 10 mg amlodipine white off-white , round , flat-faced , beveled-edge tablets , de-bossed \u201c \u045457 \u201d one side plain side . supplied follows : unit bottles 30 : 10 mg ( ndc 68645-580-54 ) storage store bottles 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant containers ( usp ) . protect light . dispense patient information available : www.epic-pharma.com/patientinfo/amlodipine-besylate-tablets.pdf distributed : epic pharma , llc laurelton , ny 11413 manufactured usa rev . 08-2023-00 mf055rev0/23 oe1189 distributed : wal-mart bentonville , ar 72716 packaged : legacy pharmaceutical packaging llc 13333 lakefront drive earth city , mo 63045",
    "adverseReactions": "amlodipine besylate tablets contraindicated patients known sensitivity amlodipine .",
    "indications_original": "Amlodipine besylate tablets are a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: Hypertension ( 1.1 ) Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Coronary Artery Disease ( 1.2 ) Chronic Stable Angina Vasospastic Angina (Prinzmetal\u2019s or Variant Angina) Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%.",
    "contraindications_original": "Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 )",
    "warningsAndPrecautions_original": "10 mg Tablets\n                  \n                  Amlodipine besylate tablets, USP equivalent to 10 mg of amlodipine are white to off-white, round, flat-faced, beveled-edge tablets, de-bossed \u201c\u040457\u201d on one side and plain on the other side. They are supplied as follows:\n                  Unit of Use Bottles of 30: 10 mg (NDC 68645-580-54)\n                  \n                     Storage\n                  \n                  Store bottles at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant containers (USP). Protect from light.\n                  \n                  Dispense with Patient Information available at: www.epic-pharma.com/patientinfo/Amlodipine-Besylate-Tablets.pdf\n                  \n                  Distributed by:\n  \nEpic Pharma, LLC\n  \nLaurelton, NY 11413\n \n                  \n                  \n                     Manufactured in USA\n                  \n                  Rev. 08-2023-00\n                  \n                  MF055REV0/23\n                  \n                  OE1189\n                  \n                  \n                     Distributed by:\n                     \nWal-Mart\n  \nBentonville, AR 72716\n \n                  \n                  \n                     Packaged by: \n                     \nLegacy Pharmaceutical Packaging LLC\n  \n13333 Lakefront Drive\n  \nEarth City, MO 63045",
    "adverseReactions_original": "Amlodipine besylate tablets are contraindicated in patients with known sensitivity to amlodipine.",
    "drug": [
        {
            "name": "AMLODIPINE BESYLATE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2668"
        }
    ]
}